Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000)

Pediatric Infectious Disease Journal

Volumn 23, Issue 1, 2004, Pages 52-55

  Lee, Kyung Yil ^a,b   Han, Ji Whan ^a   Lee, Hyung Shin ^a   Hong, Ja Hyun ^a   Hahn, Seung Hoon ^a   Lee, Joon Sung ^a   Whang, Kyung Tai ^a  

^a The Catholic University of Korea   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

Coronary artery lesions; Epidemiology; Intravenous immnoglobulin; Kawasaki disease; Korea

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; STEROID;

ACUTE DISEASE; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL FEATURE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; FATALITY; FEMALE; HOSPITAL; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEASONAL VARIATION; SEX RATIO; SOUTH KOREA; STEROID THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; KOREA; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0842325977     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000105201.92839.ec     Document Type: Article

References (26)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children (in Japanese). Jpn J Allergy 1967;16:178-222.
2. Taubert KA. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol 1997;6:181-5.
3. Yanagawa H, Kawasaki T, Shigematsu I. Nationwide survey on Kawasaki disease in Japan. Pediatrics 1987;80:58-62.
4. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995; 149:779-83.
5. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998;102:E65.
6. Yanagawa H, Nakamura Y, Ojima T, Yashiro M, Tanihara S, Oki I. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J 1999;18:64-6.
7. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:E33.
8. Park JS, Seo CJ, Cho SH, Lee DB. Clinical observation of mucocutaneous lymph node syndrome: 5 cases. J Korean Pediatr Soc 1973;16:61-7.
9. Lee DB, Lee KS, Lee BC, Lee IJ. Epidemiologic and clinical study of mucocutaneous lymph nodesyndrome in Korea. J Korean Pediatr Soc 1982;25:977-93.
10. Lee DB. Epidemiologic survey of Kawasaki syndrome in Korea (1976-1984). J Catholic Med Coll 1985;38:13-9.
11. Yun YS, Kim CH, Tockgo YC, Lee SK, Hong CY. Kawasaki disease in Korea. Proceedings of the Fifth International Kawasaki Disease Symposium, May 22 to 25, 1995. Hukuoka, Japan: Kawasaki Foundation, 1995:30-3.
12. Park YW, Kim CW, Park IS, et al. Epidemiologic study of Kawasaki disease in Korea, 1994-1996: comparison of previous study in 1991-1993. J Korean Pediatr Soc 1999;42:1255-60.
13. Park YW, Park IS, Kim CH, et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999: comparison with previous studies during 1991-1996. J Korean Med Sci 2002; 17:453-6.
14. Japan Kawasaki Disease Research Committee. Diagnostic guidelines of Kawasaki disease. 4th ed. Tokyo: Japan Kawasaki Disease Research Committee, 1984.
15. Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994;13:704-8.
16. Pelkonen P, Salo E. Epidemiology of Kawasaki disease. Clin Exp Rheumatol 1994;12(Suppl):S83-5.
17. Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 2002;324:1424-5.
18. Chang RK. Hospitalizations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics 2002; 109:e87.
19. Bell DM, Brink EW, Nitzkin JL, et al. Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med 1981;304:1568-75.
20. Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG. Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 1987;141:420-5.
21. Newberger JW, Takahashi M, Beiser AS, Burns JC, Chung KJ, Melish ME. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
22. de Zorzi A, Colan S, Gauvreau K, Baker A, Sundel R, Newburger J. Coronary dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1996;128:146-9.
23. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease: US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998;17:1144-8.
24. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9.
25. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 2000;137:177-80.
26. Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000;137:172-6.